摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(2S)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-2-yl]-2-propanesulfonamide | 877062-41-4

中文名称
——
中文别名
——
英文名称
N-[(2S)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-2-yl]-2-propanesulfonamide
英文别名
(R)-N-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-2-yl)propane-2-sulfonamide;(S)-N-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-2-yl)propane-2-sulfonamide;N-[(2S)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-2-yl]propane-2-sulfonamide
N-[(2S)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-2-yl]-2-propanesulfonamide化学式
CAS
877062-41-4
化学式
C18H28BNO4S
mdl
——
分子量
365.302
InChiKey
JLOLHMBPRDBUNQ-INIZCTEOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    488.6±55.0 °C(Predicted)
  • 密度:
    1.17±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.78
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    73
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • Structure based evolution of a novel series of positive modulators of the AMPA receptor
    作者:Craig Jamieson、John K.F. Maclean、Christopher I. Brown、Robert A. Campbell、Kevin J. Gillen、Jonathan Gillespie、Bert Kazemier、Michael Kiczun、Yvonne Lamont、Amanda J. Lyons、Elizabeth M. Moir、John A. Morrow、John Pantling、Zoran Rankovic、Lynn Smith
    DOI:10.1016/j.bmcl.2010.11.098
    日期:2011.1
    Starting from compound 1, we utilized biostructural data to successfully evolve an existing series into a new chemotype with a promising overall profile, exemplified by 19.
    从化合物1开始,我们利用生物结构数据成功地将现有系列进化为具有良好总体前景的新化学型,例如19。
  • [EN] COMPOUNDS WHICH POTENTIATE THE AMPA RECEPTOR AND USES THEREOF IN MEDICINE<br/>[FR] COMPOSÉS DE POTENTIALISATION DU RÉCEPTEUR AMPA ET LEURS UTILISATIONS EN MÉDECINE
    申请人:GLAXO GROUP LTD
    公开号:WO2010066658A1
    公开(公告)日:2010-06-17
    A compound of Formula (I) or a salt thereof are provided: wherein R is defined in the specification. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.
    提供了化合物的化学式(I)或其盐:其中R在说明书中有定义。还公开了制备方法、药物组合物以及将其用作药物的用途,例如在治疗由谷氨酸受体功能减少或失衡介导的疾病或症状,比如精神分裂症或认知障碍等。
  • COMPOUNDS WHICH POTENTIATE GLUTAMATE RECEPTOR AND USES THEREOF IN MEDICINE
    申请人:Bradley Daniel Marcus
    公开号:US20080194648A1
    公开(公告)日:2008-08-14
    Compounds of formula (I) or a pharmaceutically acceptable salt, solvate or prodrug thereof, are disclosed: wherein R 1 is C 1-6 alkyl, haloC 1-6 alkyl, C 2-6 alkenyl, amino, monoC 1-4 alkylamino or diC 1-4 alkylamino; R 2 and R 3 , which may be the same or different, are hydrogen, halogen, C 1-6 alkyl, haloC 1-6 alkyl, C 1-4 alkoxy, haloC 1-4 alkoxy, cyano, amino, monoC 1-4 alkylamino or diC 1-4 alkylamino; each R 4 , which may be the same or different, is C 1-6 alkyl, halogen, C 1-6 alkyl, haloC 1-6 alkyl, C 1-4 alkoxy, haloC 1-4 alkoxy, cyano, nitro, amino, monoC 1-4 alkylamino or diC 1-4 alkylamino; p is 0, 1 or 2; n is 1 or 2; R 5 and R 6 , which may be the same or different, are hydrogen, halogen, C 1-6 alkyl, haloC 1-6 alkyl, C 1-4 alkoxy, haloC 1-4 alkoxy, cyano, amino, monoC 1-4 alkylamino or diC 1-4 alkylamino; and Het is thienyl, pyridyl, pyrimidinyl, pyridazinyl, pyrimidinyl, pyrazinyl, imidazolyl, pyrazolyl, pyrrolyl, quinolyl, thiazolyl or furyl, each of which may be substituted by one or more groups independently selected from the list consisting of C 1-6 alkyl, C 1-6 alkoxy, acetyl, halogen, haloC 1-6 alkyl, cyano, nitro, amino, monoC 1-4 alkylamino and diC 1-4 alkylamino. Methods of preparation of the compounds, and uses thereof in medicine, for example treatment of schizophrenia, are also disclosed.
    公开了具有以下结构的化合物(I)或其药学上可接受的盐、溶剂合物或前药: 其中R1为C1-6烷基、卤代C1-6烷基、C2-6烯基、氨基、单C1-4烷基氨基或双C1-4烷基氨基;R2和R3,可以相同也可以不同,为氢、卤素、C1-6烷基、卤代C1-6烷基、C1-4烷氧基、卤代C1-4烷氧基、氰基、氨基、单C1-4烷基氨基或双C1-4烷基氨基;每个R4,可以相同也可以不同,为C1-6烷基、卤素、C1-6烷基、卤代C1-6烷基、C1-4烷氧基、卤代C1-4烷氧基、氰基、硝基、氨基、单C1-4烷基氨基或双C1-4烷基氨基;p为0、1或2;n为1或2;R5和R6,可以相同也可以不同,为氢、卤素、C1-6烷基、卤代C1-6烷基、C1-4烷氧基、卤代C1-4烷氧基、氰基、氨基、单C1-4烷基氨基或双C1-4烷基氨基;Het为噻吩基、吡啶基、嘧啶基、吡啶嗪基、嘧啶基、吡嗪基、咪唑基、吡唑基、吡咯基、喹啉基、噻唑基或呋喃基,每个基可以被一个或多个从C1-6烷基、C1-6烷氧基、乙酰基、卤素、卤代C1-6烷基、氰基、硝基、氨基、单C1-4烷基氨基和双C1-4烷基氨基的列表中独立选择的基取代。还公开了这些化合物的制备方法以及在医学上的用途,例如用于治疗精神分裂症。
  • [EN] COMPOUNDS WHICH POTENTIATE GLUTAMATE RECEPTOR AND USES THEREOF IN MEDICINE<br/>[FR] COMPOSÉS POTENTIALISATEURS DE RÉCEPTEUR DE GLUTAMATE ET UTILISATIONS DE CEUX-CI EN MÉDECINE
    申请人:GLAXO GROUP LTD
    公开号:WO2006015828A1
    公开(公告)日:2006-02-16
    Compounds which potentiate glutamate receptor and uses thereof in medicine Compounds of formula (I) or a pharmaceutically acceptable salt, solvate or prodrug thereof, are disclosed: wherein R1 is C1-6alkyl, haloC1-6 alkyl, C2-6alkenyl, amino, monoC1-4alkylamino or diC1-4alkylamino; R2 and R3, which may be the same or different, are hydrogen, halogen, C1-6alkyl, haloC1-6alkyl, C1-4alkoxy, haloC1-4alkoxy, cyano, amino, monoC1-4 alkylamino or diC1-4alkylamino; each R4, which may be the same or different, is C1-6alkyl, halogen, C1-6alkyl, haloC1-6alkyl, C1-4alkoxy, haloC1-4 alkoxy, cyano, nitro, amino, monoC1-4alkylamino or diC1-4alkylamino; p is 0, 1 or 2; n is 1 or 2; R5 and R6, which may be the same or different, are hydrogen, halogen, C1-6alkyl, haloC1-6alkyl, C1-4alkoxy, haloC1-4alkoxy, cyano, amino, monoC1-4alkylamino or diC1-4alkylamino; and Het is thienyl, pyridyl, pyrimidinyl, pyridazinyl, pyrimidinyl, pyrazinyl, imidazolyl, pyrazolyl, pyrrolyl, quinolyl, thiazolyl or furyl, each of which may be substituted by one or more groups independently selected from the list consisting of C1-6alkyl, C1-6alkoxy, acetyl, halogen, haloC1-6alkyl, cyano, nitro, amino, monoC1-4alkylamino and diC1-4alkylamino. Methods of preparation of the compounds, and uses thereof in medicine, for example treatment of schizophrenia, are also disclosed.
    本文披露了化合物公式(I)或其药学上可接受的盐、溶剂或前药,其增强谷氨酸受体的作用,并在医学上的应用:其中,R1是C1-6烷基、卤代C1-6烷基、C2-6烯基、氨基、单C1-4烷基氨基或双C1-4烷基氨基;R2和R3,可以相同也可以不同,是氢、卤素、C1-6烷基、卤代C1-6烷基、C1-4烷氧基、卤代C1-4烷氧基、氰基、氨基、单C1-4烷基氨基或双C1-4烷基氨基;每个R4,可以相同也可以不同,是C1-6烷基、卤素、C1-6烷基、卤代C1-6烷基、C1-4烷氧基、卤代C1-4烷氧基、氰基、硝基、氨基、单C1-4烷基氨基或双C1-4烷基氨基;p为0、1或2;n为1或2;R5和R6,可以相同也可以不同,是氢、卤素、C1-6烷基、卤代C1-6烷基、C1-4烷氧基、卤代C1-4烷氧基、氰基、氨基、单C1-4烷基氨基或双C1-4烷基氨基;Het为噻吩基、吡啶基、嘧啶基、吡嗪基、嘧啶基、吡嗪啉基、咪唑基、吡唑基、吡咯基、喹啉基、噻唑基或呋喃基,每个基团可以由C1-6烷基、C1-6烷氧基、乙酰基、卤素、卤代C1-6烷基、氰基、硝基、氨基、单C1-4烷基氨基和双C1-4烷基氨基中的一个或多个独立选择的基团取代。本文还披露了制备该化合物的方法以及其在医学上的应用,例如治疗精神分裂症。
  • [EN] COMPOUNDS WHICH POTENTIATE THE AMPA RECEPTOR AND USES THEREOF IN MEDICINE<br/>[FR] COMPOSÉS POTENTIATEURS DU RÉCEPTEUR AMPA ET LEURS UTILISATIONS DANS LE DOMAINE MÉDICAL
    申请人:GLAXO GROUP LTD
    公开号:WO2009080637A1
    公开(公告)日:2009-07-02
    Compounds of formula (I) and salts thereof are provided: wherein n is 0, 1, 2 or 3; R1 is selected from phenyl and pyridyl, each of which is optionally substituted by one or two groups independently selected from C1-4alkyl and halogen; and R2 is selected from H and CH3 when n is 1 and R2 is H when n is 2 or 3. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.
    提供具有化学式(I)和其盐的化合物:其中n为0、1、2或3;R1从苯基和吡啶基中选择,每种基均可选择一个或两个独立选择自C1-4烷基和卤素的基进行取代;R2在n为1时从H和CH3中选择,而在n为2或3时R2为H。还公开了制备方法、药物组合物以及将其用作药物的用途,例如用于治疗由谷氨酸受体功能减少或失衡介导的疾病或症状,如精神分裂症或认知障碍。
查看更多

同类化合物

(S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (R)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (4S,5R)-3,3a,8,8a-四氢茚并[1,2-d]-1,2,3-氧杂噻唑-2,2-二氧化物-3-羧酸叔丁酯 (3aS,8aR)-2-(吡啶-2-基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑 (3aS,3''aS,8aR,8''aR)-2,2''-环戊二烯双[3a,8a-二氢-8H-茚并[1,2-d]恶唑] (1α,1'R,4β)-4-甲氧基-5''-甲基-6'-[5-(1-丙炔基-1)-3-吡啶基]双螺[环己烷-1,2'-[2H]indene 齐洛那平 鼠完 麝香 风铃醇 颜料黄138 雷美替胺杂质14 雷美替胺杂质 雷美替胺杂质 雷美替胺杂质 雷美替胺杂质 雷美替胺杂质 雷美替胺 雷沙吉兰杂质8 雷沙吉兰杂质5 雷沙吉兰杂质4 雷沙吉兰杂质3 雷沙吉兰杂质15 雷沙吉兰杂质12 雷沙吉兰杂质 雷沙吉兰 阿替美唑盐酸盐 铵2-(1,3-二氧代-2,3-二氢-1H-茚-2-基)-8-甲基-6-喹啉磺酸酯 金粉蕨辛 金粉蕨亭 重氮正癸烷 酸性黄3[CI47005] 酒石酸雷沙吉兰 还原茚三酮(二水) 还原茚三酮 过氧化,2,3-二氢-1H-茚-1-基1,1-二甲基乙基 表蕨素L 螺双茚满 螺[茚-2,4-哌啶]-1(3H)-酮盐酸盐 螺[茚-2,4'-哌啶]-1(3H)-酮 螺[茚-1,4-哌啶]-3(2H)-酮盐酸盐 螺[环丙烷-1,2'-茚满]-1'-酮 螺[二氢化茚-1,4'-哌啶] 螺[1H-茚-1,4-哌啶]-3(2H)-酮 螺[1H-茚-1,4-哌啶]-1,3-二羧酸, 2,3-二氢- 1,1-二甲基乙酯 螺[1,2-二氢茚-3,1'-环丙烷] 藏花茚 蕨素 Z 蕨素 D 蕨素 C